UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S264

2015

Volltextzugriff (PDF)

0504 Efficacy and Safety of Seltorexant in Insomnia Disorder

Sleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A193-A193

2020

Volltextzugriff (PDF)

Nonclinical pharmacokinetic evaluation of Eteplirsen, SRP-4045, and SRP-4053: Three Phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S263

2015

Volltextzugriff (PDF)

P169 – 2697: A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping drugs, SRP-4045 and SRP-4053, in a master protocol for patients with Duchenne muscular dystrophy (DMD)

European journal of paediatric neurology, 2015-05, Vol.19, p.S141-S141

2015

Volltextzugriff (PDF)

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

International journal of impotence research, 2001-02, Vol.13 (1), p.2-9

2001

Volltextzugriff (PDF)

G.P.112

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.828-829

2014

Volltextzugriff (PDF)

PP09.5 – 2350: Pharmacokinetic evaluation of eteplirsen, SRP-4045, and SRP-4053; Three phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)

European journal of paediatric neurology, 2015-05, Vol.19, p.S66-S66

2015

Volltextzugriff (PDF)

Eteplirsen, a Phosphorodiamidate morpholino oligomer (PMO) for the treatment of Duchenne muscular dystrophy (DMD): Clinical update

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S263

2015

Volltextzugriff (PDF)

G.P.110

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.828-828

2014

Volltextzugriff (PDF)

G.O.24

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.922-922

2014

Volltextzugriff (PDF)

PP09.16 – 2691: Eteplirsen, a phosphorodiamidate morpholino oligomer (PMO) for the treatment of Duchenne muscular dystrophy (DMD): 3.2 year update on six-minute walk test (6MWT), pulmonary function testing (PFT), and safety

European journal of paediatric neurology, 2015-05, Vol.19, p.S69-S69

2015

Volltextzugriff (PDF)

S.09.04 New pharmacological treatments for negative symptoms: pitfalls and future perspectives of clinical trials

European neuropsychopharmacology, 2019-12, Vol.29, p.S6-S6

2019

Volltextzugriff (PDF)

P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.804-805

2013

Volltextzugriff (PDF)

Experience with 30 Posttraumatic Rectourethral Fistulas: Presentation of Posterior Transsphincteric Anterior Rectal Wall Advancement

The Journal of urology, 1997-08, Vol.158 (2), p.421-424

1997

Volltextzugriff (PDF)

G.P.259 - A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S264

2015

Volltextzugriff (PDF)

An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)

The American journal of cardiology, 2001-09, Vol.88 (5), p.482-487

2001

Volltextzugriff (PDF)

Serotonergic sensitivity in borderline personality disorder: preliminary findings

The American journal of psychiatry, 1994-02, Vol.151 (2), p.277-280

1994

Volltextzugriff (PDF)

Estrogen and androgen influence hypothalamic AVP and CRF concentrations in fetal and adult sheep

Regulatory peptides, 2001-04, Vol.98 (1), p.63-68

2001

Volltextzugriff (PDF)

Pharmacokinetic Properties of Chronic Administration of Eteplirsen in the Treatment of Boys with Duchenne Muscular Dystrophy (DMD) (P7.043)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

In Vitro Pharmacokinetic Evaluation of Eteplirsen, SRP-4045, and SRP-4053; Three Phosphorodiamidate Morpholino Oligomers (PMO) for the Treatment of Patients with Duchenne Muscular Dystrophy (DMD) (P5.061)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

G.P.257 - Nonclinical pharmacokinetic evaluation of Eteplirsen, SRP-4045, and SRP-4053: Three Phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S263

2015

Volltextzugriff (PDF)

G.P.112: Pulmonary function is stable through week 120 in patients with Duchenne muscular dystrophy (DMD) treated with exon-skipping drug eteplirsen in phase 2b study

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9-10), p.828-829

2014

Volltextzugriff (PDF)

Buspirone in social phobia

Journal of clinical psychopharmacology, 1993-08, Vol.13 (4), p.251-256

1993

Volltextzugriff (PDF)

Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine

Psychiatry research, 1995-09, Vol.58 (2), p.161-164

1995

Volltextzugriff (PDF)

Neuropsychiatric impairment in impulsive personality disorders

Psychiatry research, 1993-09, Vol.48 (3), p.257-266

1993

Volltextzugriff (PDF)

1 – 25 von 371

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(291)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(103)
Humans
(78)
Female
(61)
Adult
(55)
Male
(54)
Biological And Medical Sciences
(49)
Psychiatry
(46)
Medical Sciences
(40)
Psychology. Psychoanalysis. Psychiatry
(33)
Schizophrenia
(33)
Psychopathology. Psychiatry
(29)
Psychoses
(29)
Middle Aged
(28)
Adult And Adolescent Clinical Studies
(27)
Sciences Biologiques Et Medicales
(26)
Sciences Medicales
(26)
Technology
(26)
Psychologie. Psychanalyse. Psychiatrie
(22)
Psychopathologie. Psychiatrie
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

0504 Efficacy and Safety of Seltorexant in Insomnia Disorder

Nonclinical pharmacokinetic evaluation of Eteplirsen, SRP-4045, and SRP-4053: Three Phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)

P169 – 2697: A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping drugs, SRP-4045 and SRP-4053, in a master protocol for patients with Duchenne muscular dystrophy (DMD)

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

G.P.112

PP09.5 – 2350: Pharmacokinetic evaluation of eteplirsen, SRP-4045, and SRP-4053; Three phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)

Eteplirsen, a Phosphorodiamidate morpholino oligomer (PMO) for the treatment of Duchenne muscular dystrophy (DMD): Clinical update

G.P.110

G.O.24

PP09.16 – 2691: Eteplirsen, a phosphorodiamidate morpholino oligomer (PMO) for the treatment of Duchenne muscular dystrophy (DMD): 3.2 year update on six-minute walk test (6MWT), pulmonary function testing (PFT), and safety

S.09.04 New pharmacological treatments for negative symptoms: pitfalls and future perspectives of clinical trials

P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD

Experience with 30 Posttraumatic Rectourethral Fistulas: Presentation of Posterior Transsphincteric Anterior Rectal Wall Advancement

G.P.259 - A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)

Serotonergic sensitivity in borderline personality disorder: preliminary findings

Estrogen and androgen influence hypothalamic AVP and CRF concentrations in fetal and adult sheep

Pharmacokinetic Properties of Chronic Administration of Eteplirsen in the Treatment of Boys with Duchenne Muscular Dystrophy (DMD) (P7.043)

In Vitro Pharmacokinetic Evaluation of Eteplirsen, SRP-4045, and SRP-4053; Three Phosphorodiamidate Morpholino Oligomers (PMO) for the Treatment of Patients with Duchenne Muscular Dystrophy (DMD) (P5.061)

G.P.257 - Nonclinical pharmacokinetic evaluation of Eteplirsen, SRP-4045, and SRP-4053: Three Phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)

G.P.112: Pulmonary function is stable through week 120 in patients with Duchenne muscular dystrophy (DMD) treated with exon-skipping drug eteplirsen in phase 2b study

Buspirone in social phobia

Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine

Neuropsychiatric impairment in impulsive personality disorders

Suchergebnisse filtern